Recent evidence indicates that miR-155 enhanced lymphoma cell programmed death ligand 1 (PD-L1) expression, whereas PD-L1 blockade particularly retarded miR-155-overexpressing tumor growth consistent with the maintenance of CD8+ T cells and their function [510]. This evidence concerns the gene CD274 and neoplasm.